Tag Archives: drug

FDA panel criticizes agency approval of controversial $56,000 Alzheimer’s drug

The advisory panel that reviewed the controversial and expensive Alzheimer’s disease drug Aduhelm criticized the Food and Drug Administration for approving it, saying that the agency used a standard not supported by evidence. The advisory committee, known as the Peripheral and Central Nervous System Advisory Committee, examined the evidence for Aduhelm in November 2020 and… Read More »

Trade group trio raises drug shortage alarm as FDA ups its carcinogen testing efforts

Potential cancer-causing agents turning up in drugs has been a major headache for the pharma industry. But some trade groups are balking at new rules for monitoring the chemicals, arguing that they could lead to shortages of crucial drugs.  The FDA needs to change its new approach to tracking nitrosamine, three trade groups recently told the agency.… Read More »

Drug Distributors and J.&J. Reach $26 Billion Deal to End Opioids Lawsuits

Advertisement Continue reading the main story Supported by Continue reading the main story Drug Distributors and J.&J. Reach $ 26 Billion Deal to End Opioids Lawsuits The agreement would allow funds to begin flowing from the companies to states and communities to pay for addiction and prevention services. McKesson Corporation, along with Cardinal Health and… Read More »

Indian states turn to anti-parasitic drug to fight COVID-19 against WHO advice

The move by the coastal state of Goa and northern state of Uttarakhand, come despite the World Health Organisation and others warning against such measures. “The current evidence on the use of ivermectin to treat COVID-19 patients is inconclusive,” WHO said in a statement in late March. “Until more data is available, WHO recommends that… Read More »